The 39S RRNA Subunit: A Protein Subunit of Mitochondrial Ribosome

Target Name: 39S ribosomal subunit, mitochondrial

NCBI ID: P18331

39S ribosomal subunit, mitochondrial

Other Name(s): None

The 39S RRNA Subunit: A Protein Subunit of Mitochondrial Ribosome

The 39S ribosomal subunit (rRNA) is a protein that plays a crucial role in the structure and function of the mitochondria, which are organelles found in the cells of most eukaryotes. It is one of the five subunits that make up the 39S rRNA complex, which is responsible for synthesizing the protein components of the mitochondrial ribosome.

The 39S rRNA subunit is a protein that contains 18 kilodalton (kDa) of amino acids and is composed of two subunits that are held together by a disulfide bond. It is characterized by the presence of a number of conserved domains, including a amino acid loop at its N-terminus and a stalk-like structure at its C-terminus that is involved in the formation of the disulfide bond.

The 39S rRNA subunit is involved in the regulation of mitochondrial protein synthesis, and is thought to play a key role in the translation of mRNAs from the mitochondrial gene pool to the cytoplasm. It is also involved in the assembly and disassembly of the mitochondrial ribosome, and is thought to be involved in the regulation of the rate of protein synthesis in the cell.

Despite its importance for the function of the mitochondria, the 39S rRNA subunit is not well understood, and there is limited research on its potential as a drug target or biomarker. However, its potential utility as a drug target is suggested by its known interactions with a number of small molecules, including rapamycin and curcumin, which are known to inhibit the activity of the 39S rRNA subunit and may be useful for treating a variety of diseases.

The 39S rRNA subunit is also of interest as a biomarker for a number of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its expression is often reduced in the cells of cancer cells, and it has been used as a biomarker for a variety of cancer types, including breast, ovarian, and prostate cancers.

In addition to its potential as a drug target and biomarker, the 39S rRNA subunit is also of interest as a potential therapeutic target for treating a variety of disorders. For example, it is thought to be involved in the regulation of the production of autophagy, a process that is involved in the breakdown of damaged or unnecessary cellular components. Therefore, it may be useful for treating a variety of disorders, including neurodegenerative diseases, cancer, and autoimmune disorders.

In conclusion, the 39S ribosomal subunit is a protein that is involved in the structure and function of the mitochondria, and has been shown to play a number of important roles in the regulation of protein synthesis in the cell. Its potential as a drug target and biomarker, as well as its potential therapeutic applications, make it an important target for further research and development.

Protein Name: 39S Ribosomal Subunit, Mitochondrial

The "39S ribosomal subunit, mitochondrial Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about 39S ribosomal subunit, mitochondrial comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets